Document is current
Any future updates will be listed below
-
Authors
Sakuyama, Hiroki https://orcid.org/0009-0004-5844-7830
Okuyama, Hiroyuki
Tahara, Yoriyuki
Tsukamoto, Sena
Kita, Ikuhiro
Nomura, Kotone
Murakami, Akitsu
Okita, Yoshihiro
Satake, Hironaga
Kato, Takeshi
Tsuji, Akihito
- License Information
-
More Information
Article History
Received: 17 April 2026
Accepted: 9 June 2026
First Online: 25 June 2026
Declarations
:
: Hiroyuki Okuyama received lecture fees from Miyarisan Pharmaceutical, AstraZeneca, Novartis Pharma, Otsuka Pharmaceutical Factory, Chugai Pharmaceutical, Guardant Health Japan, Nihon Servier, Taiho　Pharmaceutical, MSD, and Incyte. Akitsu Murakami received lecture fees from Terumo Corporation and Daiichi Sankyo. Yoshihiro Okita received lecture fees from Daiichi Sankyo, Eli Lilly Japan, MSD, Bristol-Myers Squibb, Takeda Pharmaceutical, Merck, Eisai, Taiho Pharmaceutical, Chugai Pharmaceutical, and Ono Pharmaceutical. Hironaga Satake reports grants from Asahi KASEI; grants and personal fees from Daiichi Sankyo Co, Ltd; Kyo Diagnostics; MSD Co, Ltd; Ono Pharmaceutical Co, Ltd; Taiho Pharmaceutical Co, Ltd; and Takeda Pharmaceutical Co, Ltd; and personal fees from Astellas Pharma; AstraZeneca plc; Bayer Co, Ltd; Bristol-Myers Squibb Co, Ltd; Chugai Pharmaceutical Co, Ltd; Eli Lilly Japan Co, Ltd; Merck Bio Pharma Co, Ltd; Sanofi Co, Ltd; Yakult Honsha Co, Ltd (Takata Pharmaceutical Co. Ltd.). outside the submitted work. Takeshi Kato received lecture fees from LTT Bio-Pharma Co., Ltd.; Amgen K.K.; Bristol Myers Squibb; Miyarisan Pharmaceutical Co., Ltd.; Asahi Kasei Pharma Corporation; Ono Pharmaceutical Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Eli Lilly Japan K.K.; and Takeda Pharmaceutical Company Limited. Akihito Tsuji received lecture fees from Asahi Kasei Corporation, AstraZeneca, Eisai, Ono Pharmaceutical, Sun Pharmaceutical Industries Limited, Taiho Pharmaceutical, Chugai Pharmaceutical, Terumo Corporation, Nippon Zoki Pharmaceutical, Bayer Yakuhin, Bristol-Myers Squibb, Merck Biopharma, Takata Pharmaceutical, Zeria Pharmaceutical, LTT Bio-Pharma, Astellas Pharma, MSD, Guardant Health Japan, Daiichi Sankyo, Takeda Pharmaceutical, Tsumura, Eli Lilly Japan, Novartis Pharma, Pfizer Japan, MedPeer, Yakult Honsha, Nihon Servier, EA Pharma, and Sawai Pharmaceutical. Akihito Tsuji participated in advisory boards for Shanghai Henlius Biotech and FeliMedix. Hiroki Sakuyama, Yoriyuki Tahara, Sena Tsukamoto, Ikuhiro Kita and Kotone Nomura have no conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
